PRE-MARKET CHINESE STOCK NEWS: China had started mass production of domestically developed DUV lithography equipment, marking another advance for its domestic semiconductor manufacturing industry

Ascletis Pharma (1672 HK) - Co. reported preclinical data showing ASC37 achieved an 88% greater relative weight-loss reduction than tirzepatide in severe obesity. (Newswires)Power Construction Corporation of China (601669 CH) - Co. reported June YTD new contract value of CNY 619.9bln, down 9.7% Y/Y. (Newswires)HBM Holdings (2142 HK) - Co. and Sinopharm entered an agreement to collaborate on the research and development of innovative biologics. (Newswires)Evergrande Property Services (6666 HK) - Co.'s liquidators restarted sale talks after a previous bidder withdrew, according to a filing. (Newswires)TechChina had started mass production of domestically developed DUV lithography equipment, marking another advance for its domestic semiconductor manufacturing industry. (The Information)Anhui province generated a USD 192bln windfall profit from the listing of Chinese DRAM maker CXMT. (Newswires)Other News - China's MOFCOM called on the US to correct its approach and withdraw unilateral tariff measures imposed under Section 301 investigations. MOFCOM also said it opposed the politicisation and weaponisation of technology and trade issues following reports the US was preparing to investigate Chinese AI firms, while it added that many US AI companies had distilled Chinese models during training and development. (Newswires)